AA
IMUC

Ancora Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Ancora Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed – – 1369
2018
Q3 		$0 Buy
+50
New +$12 ﹤0.01% 1375

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Ancora Advisors's IMUC Position: Q4 2018 in Review

Ancora Advisors sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 50 shares.

Ancora Advisors first reported a position in IMUC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

  • Ancora Advisors reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
  • Ancora Advisors sold 50 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018.
  • Ancora Advisors first reported a position in ImmunoCellular Therapeutics, Ltd. in Q3 2018 and held it in 1 quarter.
  • Ancora Advisors's ImmunoCellular Therapeutics, Ltd. position peaked at $0 in Q3 2018.
  • 3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on Ancora Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.